Preclinical to Clinical Translation of Tofacitinib, a Janus Kinase Inhibitor, in Rheumatoid Arthritis
J Pharmacol Exp Ther. 2013. DOI:10.1124/jpet.113.209304
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
J Pharmacol Exp Ther. 2013. DOI:10.1124/jpet.113.209304
Pharmacological Research 2013; 76:1–8
Journal of Immunology 2013;191:3568–77
Clinical Rheumatology 2013 doi 10.1007/s10067-013-2340-1
Ann Intern Med. 2013;159;253-261
Rheumatology 2013;52:1556–1562 doi:10.1093/rheumatology/ket225
Pharmacol Ther. 2013 May; 138(2):294–309
Ann Rheum Dis. 2013 May; 72(5):741–4
International Journal of Clinical Rheumatology June 2013; 8(3):311–13
Current Rheumatology Reports 2009; 11:378-85